SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-228512
Filing Date
2019-08-26
Accepted
2019-08-26 07:10:55
Documents
3
Period of Report
2019-08-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d776062d8k.htm 8-K 18845
2 EX-99.1 d776062dex991.htm EX-99.1 46709
3 GRAPHIC g776062g0821175859136.jpg GRAPHIC 3543
  Complete submission text file 0001193125-19-228512.txt   71691
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 617-651-8851
Fulcrum Therapeutics, Inc. (Filer) CIK: 0001680581 (see all company filings)

IRS No.: 474839948 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38978 | Film No.: 191050473
SIC: 2834 Pharmaceutical Preparations